RxDoctor Payments Data

Elisa Thompson, MD

Family Medicine · Spring Hill, FLNPI 1255375689

Payments from drug & device makers

$412in general payments, 2019–2025

Across 22 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$167
  • Daiichi Sankyo Inc.$88
  • Therapeuticsmd, Inc.$34
  • Novo Nordisk$28
  • Scpharmaceuticals Inc.$25
  • Covidien LP$20
  • plus $51 from 3 others

What the payments were for

  • Food & beverage$412100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$412 in reported general payments places this provider in the 45th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$152,859
Medicare patients
341
Services billed
1,806

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban63$72,231
OzempicSemaglutide40$60,966
TrulicityDulaglutide20$42,338
JardianceEmpagliflozin20$30,394
XareltoRivaroxaban22$28,151
MounjaroTirzepatide23$27,714
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$15,952
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog14$6,814
LyricaPregabalin11$6,692
Serevent DiskusSalmeterol Xinafoate11$4,625
Insulin Lispro Kwikpen U-100Insulin Lispro11$3,206
Levothyroxine Sodium353$2,815
Rosuvastatin Calcium248$2,811
SynthroidLevothyroxine Sodium30$2,598
Bupropion XlBupropion Hcl76$2,332

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$16$70,05243 claims
Novo NordiskOzempic$28$60,96640 claims
AbbVieSynthroid$167$2,59830 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Spring Hill

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →